Ascend Capital’s Hologic HOLX Stock Holding History

Ascend Capital’s Portfolio HOLX Stock Details HOLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-257,658	Closed	-$11M	–	232
2017 Q4	$11M	Buy	+257,658	New	+$10.3M	0.41%	73
2013 Q4	–	Sell	-159,634	Closed	-$3.3M	–	206
2013 Q3	$3.3M	Sell	159,634 -380,236	-70%	-$8.09M	0.12%	160
2013 Q2	$10.4M	Buy	+539,870	New	+$11.3M	0.44%	73

Other funds holding HOLX

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Ascend Capital's HOLX Position: Q1 2018 in Review

Ascend Capital sold out of Hologic (HOLX) in Q1 2018, closing a stake of 257,658 shares — an estimated $11M sold.

Ascend Capital first reported a position in HOLX in Q2 2013 and held it in 3 quarters. The position peaked at $11M in Q4 2017. 462 funds tracked by Wall St. Rank hold HOLX as of Q1 2018.

Ascend Capital reported no remaining Hologic position as of Q1 2018 after selling out during the quarter.
Ascend Capital sold 257,658 Hologic shares in Q1 2018, an estimated $11M.
Ascend Capital first reported a position in Hologic in Q2 2013 and held it in 3 quarters.
Ascend Capital's Hologic position peaked at $11M in Q4 2017.
462 funds tracked by Wall St. Rank held Hologic as of Q1 2018.

Based on Ascend Capital's 13F filing for Q1 2018, filed 14 May 2018.